Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
HEPHAISTOS-Pharma Logo
HEPHAISTOS-Pharma Growth Score
52
CB Rank
25101
Heat Score
68
Hephaistos Pharma is a biotech company developing oncology treatments.
Founded
obfuscation
PrivateSeed Orsay, Ile-de-France, France1-10 hephaistos-pharma.fr/
Biotechnology
Oncology
Overview

HEPHAISTOS-Pharma
Total Funding
obfuscation
Growth Score
52
Heat Score
68

Total Funding
obfuscation
obfuscation
Seed raised
obfuscation
Growth Score52
1 pts
in past quarter
Heat Score 68
11 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About HEPHAISTOS-Pharma

CB Rank
25101
Hephaistos Pharma is a biotech company developing oncology treatments.
Founded
obfuscation
PrivateSeed Orsay, Ile-de-France, France1-10 hephaistos-pharma.fr/
Biotechnology
Oncology

Funding Rounds

Seed
OBF
in
obfuscation
Grant
OBF
in
obfuscation
Grant
OBF
in
obfuscation

Key People

Details

Legal Name HEPHAISTOS-PHARMA, SAS
Operating Status Active
Company Type For Profit
Founders  Martine Caroff
About the Company
Hephaistos Pharma is a developing weapons firm. They provide services for oncology, immunotherapy, and cancer. An online inquiry form is available on the company's website.
Predictions & Insights

Growth Insight

See this Growth Insight
HEPHAISTOS-Pharma is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Growth Insight

Products & Services

ONCO-Boost
An immunostimulant drug candidate designed to activate innate and adaptive immune responses against cold tumors, administered intravenously for treating solid and hematologic cancers.
HEPHA-440
A systemic detoxified and augmented TLR4 activator drug candidate targeting refractory solid and liquid cancers to overcome tumor immune evasion.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 4
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - HEPHAISTOS-Pharma Logo
Seed Round - HEPHAISTOS-Pharma
6
obfuscation
Elaia, Fournier-Majoie, XISTA Science VenturesSeed
obfuscation
Seed Round - HEPHAISTOS-Pharma Logo
Seed Round - HEPHAISTOS-Pharma
6
obfuscation
Elaia, Fournier-Majoie, XISTA Science VenturesSeed
obfuscation
Seed Round - HEPHAISTOS-Pharma Logo
Seed Round - HEPHAISTOS-Pharma
6
obfuscation
Elaia, Fournier-Majoie, XISTA Science VenturesSeed
obfuscation
Seed Round - HEPHAISTOS-Pharma Logo
Seed Round - HEPHAISTOS-Pharma
6
obfuscation
Elaia, Fournier-Majoie, XISTA Science VenturesSeed
obfuscation
Seed Round - HEPHAISTOS-Pharma Logo
Seed Round - HEPHAISTOS-Pharma
6
obfuscation
Elaia, Fournier-Majoie, XISTA Science VenturesSeed

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 4
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - HEPHAISTOS-Pharma Logo
Seed Round - HEPHAISTOS-Pharma
6
obfuscation
Elaia, Fournier-Majoie, XISTA Science VenturesSeed
obfuscation
Seed Round - HEPHAISTOS-Pharma Logo
Seed Round - HEPHAISTOS-Pharma
6
obfuscation
Elaia, Fournier-Majoie, XISTA Science VenturesSeed
obfuscation
Seed Round - HEPHAISTOS-Pharma Logo
Seed Round - HEPHAISTOS-Pharma
6
obfuscation
Elaia, Fournier-Majoie, XISTA Science VenturesSeed
obfuscation
Seed Round - HEPHAISTOS-Pharma Logo
Seed Round - HEPHAISTOS-Pharma
6
obfuscation
Elaia, Fournier-Majoie, XISTA Science VenturesSeed
obfuscation
Seed Round - HEPHAISTOS-Pharma Logo
Seed Round - HEPHAISTOS-Pharma
6
obfuscation
Elaia, Fournier-Majoie, XISTA Science VenturesSeed

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 5 Board Members and Advisors 1 Contacts 3

Employee Profiles

Board Members and Advisors

News

News and Press

News•May 22, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 19, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 25, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 25, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

221
820.83%
 in past month

IT Spend

$36KThis year, HEPHAISTOS-Pharma is projected to spend $36K on IT, according to Aberdeen.

Active Website Tech Count

32HEPHAISTOS-Pharma is actively using 32 technologies for its website, according to BuiltWith. These include IPhone / Mobile Compatible, Viewport Meta, and  SSL by Default.

Total IP

2HEPHAISTOS-Pharma has 1 registered patent in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery. Additionally, HEPHAISTOS-Pharma has 1 registered trademark in the 'Chemical substances' class, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is HEPHAISTOS-Pharma's headquarters? HEPHAISTOS-Pharma is located in Orsay, Ile-de-France, France.Who invested in HEPHAISTOS-Pharma? HEPHAISTOS-Pharma has 10 investors including XISTA Science Ventures and  Elaia.When was the last funding round for HEPHAISTOS-Pharma? HEPHAISTOS-Pharma closed its last funding round on
obfuscation
from a Seed round.Who are HEPHAISTOS-Pharma's competitors? Alternatives and possible competitors to HEPHAISTOS-Pharma may include Elicio Therapeutics, ImmunityBio, and  Agenus.How much funding has HEPHAISTOS-Pharma raised to date? HEPHAISTOS-Pharma has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(2e7868f 1)
|